AFP Clinical Answers

Gastroenteritis, Borderline Personality Disorder, Nonalcoholic Steatohepatitis, COPD

 

Am Fam Physician. 2019 Sep 1;100(5):273.

What is an effective treatment for mild dehydration in children with gastroenteritis?

The specific electrolyte composition of oral rehydration solution is not important for mild dehydration. Half-strength apple juice followed by preferred fluids (regular juices, milk) is an option for mild dehydration, because a study found this approach reduced the need for eventual intravenous rehydration compared with a formal oral rehydration solution.

https://www.aafp.org/afp/2019/0201/p159.html

Are any medications effective in the treatment of borderline personality disorder?

There is no pharmacotherapy regimen that improves the overall symptoms of borderline personality disorder. When used for six months or less, antipsychotics can improve paranoia, dissociation, mood lability, anger, and global functioning. When used for six months or less, aripiprazole (Abilify), olanzapine (Zyprexa), lamotrigine (Lamictal), topiramate (Topamax), omega-3 fatty acids, and valproate (Depacon) can decrease anger, anxiety, depression, and impulsivity.

https://www.aafp.org/afp/2019/0301/od2.html

How effective is metformin in the treatment of NAFLD and nonalcoholic steatohepatitis?

Metformin does not seem to be an effective treatment for nonalcoholic steatohepatitis. There are no studies evaluating whether metformin improves long-term patient-oriented outcomes such as progression from nonalcoholic fatty liver disease (NAFLD) to nonalcoholic steatohepatitis, cirrhosis, hepatocellular carcinoma, or death from liver failure. Metformin does not improve anatomic outcomes (histologic or ultrasound features of the liver) or biochemical outcomes (alanine transaminase and aspartate transaminase levels, or insulin resistance) in adults. Metformin does not improve liver histologic or biochemical outcomes or body mass index in adults with non-alcoholic steatohepatitis or in children and adolescents with NAFLD.

https://www.aafp.org/afp/2019/0215/p262.html

Are shorter courses of systemic corticosteroid therapy as safe and effective as longer courses for patients with exacerbations of COPD?

Based on a Cochrane review, treatment of acute exacerbations of chronic obstructive pulmonary disease (COPD) with a shorter course of systemic corticosteroids (seven or fewer days) is likely to be as effective and safe as treating with longer courses (more than seven days). There is no significant difference in adverse effects between shorter and longer courses. Current guidelines from the Global Initiative for Chronic Obstructive Lung Disease recommend treating acute exacerbations of COPD with oral prednisone, 40 mg per day for five days in most patients.

https://www.aafp.org/afp/2019/0301/p295.html

Tip for Using AFP at the Point of Care

Looking for more information about COPD or gastroenteritis? Check out the collections of content about COPD, gastroenteritis in children, and related issues in AFP By Topic at https://www.aafp.org/afp/COPD and https://www.aafp.org/afp/gi-children. You will find 70 topic collections (e.g., asthma, health maintenance and counseling, influenza) at https://www.aafp.org/afp/topics.

A collection of AFP Clinical Answers published in AFP is available at https://www.aafp.org/afp/answers.

 

 

Copyright © 2019 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


More in Pubmed

MOST RECENT ISSUE


Nov 1, 2020

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article